Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
about
Additive effects of atorvastatin combined with sitagliptin on rats with myocardial infarction: a pilot studyEffect of Dipeptidyl Peptidase-4 Inhibitor on All-Cause Mortality and Coronary Revascularization in Diabetic Patients.Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials.Dipeptidyl peptidase IV inhibitors and ischemic myocardial injury.DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway.Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.
P2860
Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
@en
type
label
Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
@en
prefLabel
Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
@en
P2093
P2860
P1433
P1476
Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
@en
P2093
Dongsheng Dai
Federico Mercanti
Jawahar L Mehta
Xianwei Wang
Zufeng Ding
P2860
P2888
P304
P356
10.1007/S00592-013-0496-4
P577
2013-07-04T00:00:00Z
P5875
P6179
1026279121